2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Industry-Specific Factors Are Fueling the Growth of theThyroid Eye Disease (TED) Market?

The increasing occurrence of thyroid disorders is expected to drive the expansion of the thyroid eye disease (TED) market in the future. Thyroid disorders are medical conditions that affect the thyroid gland’s function, leading to hormonal imbalances that cause conditions like hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. The rise in thyroid disorders is attributed to factors such as increased iodine intake, autoimmune diseases, genetic factors, and greater awareness leading to improved diagnosis rates. Thyroid Eye Disease (TED) is a common complication of Graves’ disease, which contributes to the growing awareness and incidence of thyroid-related conditions. For example, in May 2024, the Canadian Cancer Society projected that 6,600 new thyroid cancer cases would be diagnosed in Canada in 2024, with about 280 expected fatalities. Therefore, the increasing prevalence of thyroid disorders is driving the growth of the thyroid eye disease (TED) market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21300&type=smp

#How Will the CAGR of the Thyroid Eye Disease (TED) Market Influence Its Overall Growth by 2034?

The thyroid eye disease (TED) market has expanded significantly, growing from $2.15 billion in 2024 to $2.30 billion in 2025 at a CAGR of 7.0%. This growth is driven by rising thyroid disorders, an increased focus on patient-centered care, greater demand for cosmetic procedures, a higher prevalence of TED, and expanding treatment options.

The thyroid eye disease (TED) market is projected to witness substantial growth, reaching $2.97 billion by 2029, with a CAGR of 6.6%. Growth drivers include the rising prevalence of Graves’ disease, increasing investments across various industries, growing healthcare expenditures, greater use of thyroid hormone replacement therapy, and an increasing incidence of thyroid-related disorders. Major trends anticipated in this period include advancements in technology, expanding R&D efforts, the introduction of novel drug therapies, enhanced treatment options, and new surgical techniques.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21300

What Key Market Trends and Innovations Are Shaping the Future of theThyroid Eye Disease (TED) Industry?

In the thyroid eye disease (TED) market, companies are focusing on innovative treatments such as monoclonal antibody therapies to improve patient outcomes. These therapies use laboratory-made antibodies to target specific components of the immune system, reducing inflammation and other TED symptoms. For example, in September 2024, Amgen Inc. received approval from Japan’s Ministry of Health for TEPEZZA (teprotumumab), the first FDA-approved therapy specifically for TED. This approval offers a targeted solution for patients with active thyroid eye disease, helping to reduce symptoms like eye bulging, pain, and vision problems.

Which Companies Are Leading the Charge in Expanding theThyroid Eye Disease (TED) Market Growth?

Major companies operating in the thyroid eye disease (TED) market are Hoffmann-La Roche AG, Amgen Inc., Genentech Inc., Horizon Therapeutics plc, Pierre Fabre S.A., Innovent Biologics Inc., ACELYRIN Inc., Soleo Health, Zai Lab Limited, HanAll Biopharma Co. Ltd., Tourmaline Bio Inc., Zenas BioPharma Inc., Immunovant Inc., Verana Health, Harbour BioMed (Guangzhou) Co. Ltd., Sling Therapeutics Inc., Crinetics Pharmaceuticals Inc., Lassen Therapeutics Inc., Viridian Therapeutics Inc., Minghui Pharmaceutical Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/thyroid-eye-disease-ted-global-market-report

How is the Global Thyroid Eye Disease (TED) Market Segemented?

The thyroid eye disease (TED) market covered in this report is segmented –

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical

2) By Disease Severity: Mild, Moderate, Severe

3) By Drug Type: Biologics, Small Molecules, Others Drug Type

4) By Route Of Administration: Oral, Intravenous, Subcutaneous

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications, Other Medical Treatments

2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery, Other Combined Approaches

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=21300&type=smp

Which Geographics are Influencing the Growth of the Thyroid Eye Disease (TED) Market?

North America was the largest region in the thyroid eye disease (TED) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (TED) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Thyroid Eye Disease (TED) Market 2025, By The Business Research Company:

Digestive Enzymes Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-enzyme-global-market-report

Digestive Health Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-health-global-market-report

Digestive Health Supplements Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/digestive-health-supplements-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: